Efficacy of intraperitoneal amino acid (IPAA) dialysate in an Asian vegetarian patient with chronic hypoalbuminaemia.
Protein-calorie malnutrition is commonly found in chronic CAPD patients and is a matter of concern since low serum albumin levels correlate with an increased risk of morbidity and mortality. Recognition of this link has therefore led to a growing interest in the efficacy of IPAA therapy as a possible treatment option. The present case study took place within a larger, ongoing clinical trial and outlines our experience of administering one exchange of 1.1% IPAA (Nutrineal, Baxter Healthcare Ltd) per day over 18 weeks to a patient identified as being protein malnourished.
Steele
M
M
Royal London Hospital.
Yokum
D
D
Armstrong
A
A
D000596:Amino Acids / Q000627:therapeutic use*; D001806:Blood Urea Nitrogen; D018592:Cross-Over Studies; D015314:Dialysis Solutions / Q000627:therapeutic use*; D014676:Diet, Vegetarian / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D011502:Protein-Energy Malnutrition / Q000188:drug therapy* / Q000209:etiology* / Q000378:metabolism; D012709:Serum Albumin / Q000172:deficiency*
D000596:Amino Acids; D015314:Dialysis Solutions; D012709:Serum Albumin